Literature DB >> 22713208

Bacterial responses to a simulated colon tumor microenvironment.

Annemarie Boleij1, Bas E Dutilh, Guus A M Kortman, Rian Roelofs, Coby M Laarakkers, Udo F Engelke, Harold Tjalsma.   

Abstract

One of the few bacteria that have been consistently linked to colorectal cancer (CRC) is the opportunistic pathogen Streptococcus gallolyticus. Infections with this bacterium are generally regarded as an indicator for colonic malignancy, while the carriage rate of this bacterium in the healthy large intestine is relatively low. We speculated that the physiological changes accompanying the development of CRC might favor the colonization of this bacterium. To investigate whether colon tumor cells can support the survival of S. gallolyticus, this bacterium was grown in spent medium of malignant colonocytes to simulate the altered metabolic conditions in the CRC microenvironment. These in vitro simulations indicated that S. gallolyticus had a significant growth advantage in these spent media, which was not observed for other intestinal bacteria. Under these conditions, bacterial responses were profiled by proteome analysis and metabolic shifts were analyzed by (1)H-NMR-spectroscopy. In silico pathway analysis of the differentially expressed proteins and metabolite analysis indicated that this advantage resulted from the increased utilization of glucose, glucose derivates, and alanine. Together, these data suggest that tumor cell metabolites facilitate the survival of S. gallolyticus, favoring its local outgrowth and providing a possible explanation for the specific association of S. gallolyticus with colonic malignancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713208      PMCID: PMC3494137          DOI: 10.1074/mcp.M112.019315

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  38 in total

Review 1.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

2.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors:  Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

3.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Authors:  D A Lieberman; D G Weiss; J H Bond; D J Ahnen; H Garewal; G Chejfec
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

Review 4.  Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer.

Authors:  Annemarie Boleij; Harold Tjalsma
Journal:  Biol Rev Camb Philos Soc       Date:  2012-02-02

Review 5.  Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.

Authors:  Annemarie Boleij; Marleen M H J van Gelder; Dorine W Swinkels; Harold Tjalsma
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

Review 6.  Mucin macromolecules in normal, adenomatous, and carcinomatous colon: evidence for the neotransformation.

Authors:  Nurten Aksoy; O Faruk Akinci
Journal:  Macromol Biosci       Date:  2004-05-17       Impact factor: 4.979

Review 7.  How host-microbial interactions shape the nutrient environment of the mammalian intestine.

Authors:  Lora V Hooper; Tore Midtvedt; Jeffrey I Gordon
Journal:  Annu Rev Nutr       Date:  2002-04-04       Impact factor: 11.848

8.  Complete genome sequence of Lactobacillus plantarum WCFS1.

Authors:  Michiel Kleerebezem; Jos Boekhorst; Richard van Kranenburg; Douwe Molenaar; Oscar P Kuipers; Rob Leer; Renato Tarchini; Sander A Peters; Hans M Sandbrink; Mark W E J Fiers; Willem Stiekema; René M Klein Lankhorst; Peter A Bron; Sally M Hoffer; Masja N Nierop Groot; Robert Kerkhoven; Maaike de Vries; Björn Ursing; Willem M de Vos; Roland J Siezen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

9.  Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov.

Authors:  Laurent Schlegel; Francine Grimont; Elisabeth Ageron; Patrick A D Grimont; Anne Bouvet
Journal:  Int J Syst Evol Microbiol       Date:  2003-05       Impact factor: 2.747

10.  Towards the human colorectal cancer microbiome.

Authors:  Julian R Marchesi; Bas E Dutilh; Neil Hall; Wilbert H M Peters; Rian Roelofs; Annemarie Boleij; Harold Tjalsma
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

View more
  16 in total

1.  Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization.

Authors:  Laetitia Aymeric; Françoise Donnadieu; Céline Mulet; Laurence du Merle; Giulia Nigro; Azadeh Saffarian; Marion Bérard; Claire Poyart; Sylvie Robine; Béatrice Regnault; Patrick Trieu-Cuot; Philippe J Sansonetti; Shaynoor Dramsi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

Review 2.  Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.

Authors:  Marwa ElRakaiby; Bas E Dutilh; Mariam R Rizkallah; Annemarie Boleij; Jason N Cole; Ramy K Aziz
Journal:  OMICS       Date:  2014-05-02

3.  Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Authors:  Julia Butt; William J Blot; Lauren R Teras; Kala Visvanathan; Loïc Le Marchand; Christopher A Haiman; Yu Chen; Ying Bao; Howard D Sesso; Sylvia Wassertheil-Smoller; Gloria Y Ho; Lesley F Tinker; Richard M Peek; John D Potter; Timothy L Cover; Laura H Hendrix; Li-Ching Huang; Tim Waterboer; Michael Pawlita; Meira Epplein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

4.  The Pil3 pilus of Streptococcus gallolyticus binds to intestinal mucins and to fibrinogen.

Authors:  Mariana Martins; Constance Porrini; Laurence du Merle; Camille Danne; Catherine Robbe-Masselot; Patrick Trieu-Cuot; Shaynoor Dramsi
Journal:  Gut Microbes       Date:  2016-09-22

Review 5.  Microbes, microbiota, and colon cancer.

Authors:  Cynthia L Sears; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

6.  Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas.

Authors:  Julia L Nugent; Amber N McCoy; Cassandra J Addamo; Wei Jia; Robert S Sandler; Temitope O Keku
Journal:  J Proteome Res       Date:  2014-03-21       Impact factor: 4.466

7.  Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development.

Authors:  Ritesh Kumar; Jennifer L Herold; Deborah Schady; Jennifer Davis; Scott Kopetz; Margarita Martinez-Moczygemba; Barbara E Murray; Fang Han; Yu Li; Evelyn Callaway; Robert S Chapkin; Wan-Mohaiza Dashwood; Roderick H Dashwood; Tia Berry; Chris Mackenzie; Yi Xu
Journal:  PLoS Pathog       Date:  2017-07-13       Impact factor: 6.823

8.  Significance of infectious agents in colorectal cancer development.

Authors:  Vlado Antonic; Alexander Stojadinovic; Kent E Kester; Peter J Weina; Björn Ldm Brücher; Mladjan Protic; Itzhak Avital; Mina Izadjoo
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

9.  Microbiome analysis of stool samples from African Americans with colon polyps.

Authors:  Hassan Brim; Shibu Yooseph; Erwin G Zoetendal; Edward Lee; Manolito Torralbo; Adeyinka O Laiyemo; Babak Shokrani; Karen Nelson; Hassan Ashktorab
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

10.  Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas.

Authors:  Yingying Lu; Jing Chen; Junyuan Zheng; Guoyong Hu; Jingjing Wang; Chunlan Huang; Lihong Lou; Xingpeng Wang; Yue Zeng
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.